Skip to content
Clinical Trials – home
Institut De Cancerologie De L Ouest
Sponsor

Institut De Cancerologie De L Ouest

France Bd Du Professeur Jacques Monod, 44800 Saint-Herblain, France

About the sponsor

Breast cancer research includes triple-negative breast cancer and the management of disease-related complications such as brain metastases. The sponsor also supports work on fertility preservation before systemic treatment, including ovarian stimulation and cryopreservation strategies.

  • Triple-negative breast cancer
  • Brain metastases in breast cancer
  • Fertility preservation before chemotherapy

These activities reflect interest in both disease control and treatment-related quality-of-life issues in women with cancer.

About Specializations

Institut De Cancerologie De L Ouest runs clinical trials in conditions such as Triple negative breast cancer, Breast cancer, Metastases to central nervous system, Neuropathy peripheral, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

9 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gallium (68Ga)
  • Sponsor:Institut De Cancerologie De L Ouest
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Cetrorelix
  • Sponsor:Institut De Cancerologie De L Ouest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Institut De Cancerologie De L Ouest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capsaicin
  • Sponsor:Institut De Cancerologie De L Ouest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Institut De Cancerologie De L Ouest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bemarituzumab
  • Sponsor:Institut De Cancerologie De L Ouest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Denosumab
  • Sponsor:Institut De Cancerologie De L Ouest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorodopa (18F)
  • Sponsor:Institut De Cancerologie De L Ouest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Institut De Cancerologie De L Ouest

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.